724422-42-8

Basic information

• Product Name: 6-Bromo-2-methyl-3,4-dihydroisoquinolin-1(2H)-one
• Synonyms: 6-Bromo-2-methyl-3,4-dihydroisoquinolin-1(2H)-one;1(2H)-ISOQUINOLINONE, 6-BROMO-3,4-DIHYDRO-2-METHYL-
• CAS NO: 724422-42-8
• Molecular Formula: C₁₀H₁₀BrNO
• Molecular Weight: 240.0965
• Mol File: 724422-42-8.mol
• Article Data: 9

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 6-Bromo-2-methyl-3,4-dihydroisoquinolin-1(2H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 6-Bromo-2-methyl-3,4-dihydroisoquinolin-1(2H)-one(724422-42-8)
• EPA Substance Registry System: 6-Bromo-2-methyl-3,4-dihydroisoquinolin-1(2H)-one(724422-42-8)

Safety Data

• Hazardous Substances Data: 724422-42-8(Hazardous Substances Data)

Usage

General Description

6-Bromo-2-methyl-3,4-dihydroisoquinolin-1(2H)-one is a chemical compound with the molecular formula C10H10BrNO. It is a derivative of isoquinolin-1(2H)-one, and its structure includes a bromine atom and a methyl group. 6-Bromo-2-methyl-3,4-dihydroisoquinolin-1(2H)-one has potential pharmaceutical applications due to its structural similarity to other bioactive molecules. It may also have potential use as an intermediate in organic synthesis. However, its specific properties, uses, and potential hazards would need to be further investigated and determined through thorough research and testing.

Upstream product

• 34598-49-7 5-Bromo-1-indanone 
• 147497-32-3 6-bromo-3,4-dihydroisoquinolin-1(2H)-one 
• 74-88-4 methyl iodide 
• 1313399-72-2 methyl 3-bromophenethyl(methyl)carbamate 

Downstream Products

• 1131223-44-3 2-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinolin-1-one 
• 1209490-17-4 C₂₃H₂₃N₅O₃ 

Relevant articles and documents

CDK6 inhibitor of pyrimidine benzo six-membered ring mother nucleus as well as preparation method and application of CDK6 inhibitor

The invention discloses a CDK6 inhibitor of a pyrimidine benzo six-membered ring mother nucleus and a preparation method and application of the CDK6 inhibitor, the compound structure of the CDK6 inhibitor is shown as a formula (C), and A is selected from O, C (O) or-NR1; R1 is selected from hydrogen or C1-C8 alkyl; B is selected from O or C; X is selected from C, C (O) or-NR2; R2 is selected from hydrogen or C1-C8 alkyl; Y is selected from C (O) or (CH2) n; n is 0 or 1; and Z is selected from hydrogen, C1-C8 alkyl or-C (O) OC1-C3. The invention also discloses a preparation method and application of the compound.

Heterocyclic Compounds and Methods of Use

This disclosure provides compounds and methods of using those compounds to treat metabolic disorders and hyperproliferative disorders, including administration of the compounds in conjunction with hormone receptor antagonists.

SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C

This invention relates to 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)- amides of formula (1) and their use as inhibitors of Cathepsin C, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of diseases connected with dipeptidyl peptidase I activity, e.g. respiratory diseases.